Transplantation

Transplantation

Global Transplantation Market to Reach US$22.7 Billion by 2030

The global market for Transplantation estimated at US$14.0 Billion in the year 2023, is expected to reach US$22.7 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Organ transplantation, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Tissue transplantation segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 11.7% CAGR

The Transplantation market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Transplantation Market - Key Trends & Drivers Summarized

What Is Transplantation and Why Is It Vital?

Transplantation is a medical procedure that involves transferring organs, tissues, or cells from a donor to a recipient to restore function in a damaged or failing body part. Common types of transplants include kidney, liver, heart, lung, and bone marrow transplants. Transplantation is vital for saving lives and improving the quality of life for patients with end-stage organ failure and certain diseases. The success of transplantation relies on matching donors and recipients, managing immune responses, and ensuring long-term graft survival. Advances in transplantation techniques and immunosuppressive therapies have significantly improved transplant outcomes, making it a critical component of modern medicine.

How Have Technological Advances Impacted the Market?

Technological advances have profoundly impacted the transplantation market. Innovations in surgical techniques, such as minimally invasive and robotic-assisted surgeries, have improved the precision and outcomes of transplant procedures. The development of advanced immunosuppressive drugs has enhanced the management of transplant rejection and improved graft survival rates. Advances in organ preservation and transportation technologies, such as machine perfusion and cold storage solutions, have extended the viability of donor organs, increasing the success rates of transplants. Additionally, regenerative medicine and stem cell research have opened new possibilities for creating bioengineered organs and tissues, addressing the shortage of donor organs. These technological advancements have expanded the scope and effectiveness of transplantation, driving market growth.

Who Are the Key Stakeholders and What Are Their Needs?

The key stakeholders in the transplantation market include transplant centers, hospitals, organ procurement organizations, pharmaceutical companies, and patients. Transplant centers and hospitals perform transplant procedures and provide post-transplant care, requiring access to high-quality donor organs, advanced surgical tools, and effective immunosuppressive therapies. Organ procurement organizations coordinate the donation and distribution of organs, seeking efficient and reliable organ preservation and transportation solutions. Pharmaceutical companies develop immunosuppressive drugs and other therapies to manage transplant rejection and improve outcomes, requiring robust clinical research and development capabilities. Patients rely on successful transplantation to restore their health and quality of life, seeking access to timely and effective transplant services. Each stakeholder group demands innovative and effective solutions to address the complex challenges of transplantation.

What Is Driving Growth in the Transplantation Market?

The growth in the transplantation market is driven by several factors, including the increasing prevalence of organ failure, advancements in transplantation techniques, and the rising demand for organ transplants. The growing incidence of chronic diseases, such as diabetes, cardiovascular diseases, and liver cirrhosis, has led to an increase in organ failures, driving the demand for transplantation. Advancements in transplantation techniques, such as improved surgical methods and immunosuppressive therapies, have enhanced transplant success rates and expanded the pool of eligible recipients. The rising demand for organ transplants, driven by increasing awareness and acceptance of organ donation, has further fueled market growth. Additionally, government initiatives and funding for transplant programs and research have supported the expansion and development of the transplantation market.

Select Competitors (Total 118 Featured) -

• Abbott Laboratories, Inc.
• Acelity LP, Inc.
• Avioq, Inc.
• AxoGen, Inc.
• BD Biosciences
• BioLife Solutions Inc.
• Bio-Rad Laboratories, Inc.
• CareDx, Inc.
• Carmat SA
• Chronix Biomedical
• Dr. Franz Kohler Chemie GmbH
• F. Hoffmann-La Roche AG
• GenDx
• Histogenics Corporation
• Illumina, Inc.
• Luminex Corporation
• Medipex Limited
• Miromatrix Medical Inc.
• Nano Dimension Ltd.
• Organovo Holdings, Inc.
• Ortho Clinical Diagnostics
• Oxford Immunotec Global PLC
• Pacific Biosciences of California, Inc.
• Pandorum Technologies Pvt. Ltd.
• Qiagen NV
• Siemens Healthineers
• SynCardia
• Thermo Fisher Scientific, Inc.
• Transplant Biomedicals S.L.
• XVIVO Perfusion AB

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.